The Pharmacopoeial Discussion Group (PDG), which brings together the European Pharmacopoeia (Ph. Eur.), the Japanese Pharmacopoeia (JP) and the United States Pharmacopeia (USP), with the World Health Organization (WHO) as observer, held its annual autumn meeting from 18 to 21 October 2022. Due to the COVID-19 pandemic, the meeting was again organised through videoconference. For the first time, the Indian Pharmacopoeia Commission (IPC) joined the meeting as a pilot participant in the PDG pilot for global expansion.
The PDG members were delighted to welcome the IPC. The IPC introduced its organisational structure, its pharmacopoeia and its plan for harmonising with the PDG. This was a landmark meeting in the PDG’s 33-year history since the PDG welcomed an additional pharmacopoeia, marking the launch of a one-year pilot for expansion of its membership, as announced in an earlier press release. The lessons learned from this pilot will be used to further adjust and refine the group’s working methods and will identify any changes necessary to ensure that the PDG continues to perform efficiently at the end of the pilot.
For more information, read the press release “Pharmacopoeial Discussion Group achievements”.